Search

Author/Creator Lutgens, M

1. DOP70 Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study. (21st January 2022)

Authors:
Mahmoud, R; Savelkoul, E; Mares, W; Goetgebuer, R; Witteman, B; de Koning, D; Minderhoud, I; van Tuyl, S; van Boeckel, P; Mahmmod, N; Lutgens, M; Horjus, C; Römkens, T; Akol-Simsek, D; Jansen, J; Hoentjen, F; Jharap, B; Oldenburg, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P309 Withdrawal of thiopurines in Inflammatory Bowel Disease patients in stable remission: a prospective, multicentre cohort study. (21st January 2022)

Authors:
Savelkoul, E; Mahmoud, R; De Jong, D; Van Dop, W; Römkens, T; Nissen, L; Mahmmod, N; Van Boeckel, P; Lutgens, M; Mares, W; Epping, L; Minderhoud, I; Jansen, J; Gisbertz, I; Boekema, P; De Koning, D; Horjus, C; Jharap, B; Oldenburg, B; Hoentjen, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i335
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P384 A higher red blood cell methotrexate polyglutamate 3 concentration is associated with methotrexate drug-survival in patients with Crohn's Disease: first results of a prospective cohort. (30th January 2023)

Authors:
Van De Meeberg, M; Fidder, H; Sundaresan, J; Struys, E; Oldenburg, B; Mares, W; Mahmmod, N; van Asseldonk, D; Lutgens, M; Kuyvenhoven, J; Rietdijk, S; Nissen, L; Koehestanie, P; de Jonge, R; Bulatović Ćalasan, M; Bouma, G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i518
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial. (30th January 2023)

Authors:
Van Linschoten, R; Jansen, F; Pauwels, R; Smits, L; Atsma, F; Kievit, W; de Jong, D; de Vries, A; Boekema, P; West, R; Bodelier, A; Gisbertz, I; Wolfhagen, F; Romkens, T; Lutgens, M; van Bodegraven, A; Oldenburg, B; Pierik, M; Russel, M; de Boer, N
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P816 The efficacy of an over the counter multivitamin and mineral supplement to prevent opportunistic infections in patients with inflammatory bowel disease in remission. (30th January 2023)

Authors:
Laheij, R; van Knippenberg, Y; Heil, A; Mannaerts, B; Bruin, K; Lutgens, M; Sikkema, M; de Wit, U; Laheij, R
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i950
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search